1. Home
  2. NTHI vs PLL Comparison

NTHI vs PLL Comparison

Compare NTHI & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • PLL
  • Stock Information
  • Founded
  • NTHI 2008
  • PLL 2016
  • Country
  • NTHI United States
  • PLL United States
  • Employees
  • NTHI N/A
  • PLL N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • PLL Other Metals and Minerals
  • Sector
  • NTHI Health Care
  • PLL Basic Materials
  • Exchange
  • NTHI Nasdaq
  • PLL Nasdaq
  • Market Cap
  • NTHI 155.4M
  • PLL 184.1M
  • IPO Year
  • NTHI N/A
  • PLL 2017
  • Fundamental
  • Price
  • NTHI $9.88
  • PLL N/A
  • Analyst Decision
  • NTHI
  • PLL Hold
  • Analyst Count
  • NTHI 0
  • PLL 5
  • Target Price
  • NTHI N/A
  • PLL $10.31
  • AVG Volume (30 Days)
  • NTHI 72.4K
  • PLL 690.8K
  • Earning Date
  • NTHI 08-19-2025
  • PLL 08-07-2025
  • Dividend Yield
  • NTHI N/A
  • PLL N/A
  • EPS Growth
  • NTHI N/A
  • PLL N/A
  • EPS
  • NTHI N/A
  • PLL N/A
  • Revenue
  • NTHI $59,990.00
  • PLL $105,102,000.00
  • Revenue This Year
  • NTHI N/A
  • PLL N/A
  • Revenue Next Year
  • NTHI N/A
  • PLL $33.37
  • P/E Ratio
  • NTHI N/A
  • PLL N/A
  • Revenue Growth
  • NTHI N/A
  • PLL 58.18
  • 52 Week Low
  • NTHI $3.20
  • PLL $5.15
  • 52 Week High
  • NTHI $25.00
  • PLL $15.44
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • PLL 14.27
  • Support Level
  • NTHI N/A
  • PLL $8.48
  • Resistance Level
  • NTHI N/A
  • PLL $9.43
  • Average True Range (ATR)
  • NTHI 0.00
  • PLL 0.27
  • MACD
  • NTHI 0.00
  • PLL -0.87
  • Stochastic Oscillator
  • NTHI 0.00
  • PLL 0.00

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About PLL Piedmont Lithium Inc.

Piedmont Lithium Inc, is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and world-wide energy security. Its portfolio of wholly-owned projects includes Carolina Lithium, a proposed fully integrated spodumene ore-to-lithium hydroxide project in Gaston County, North Carolina, and Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee.

Share on Social Networks: